These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29860311)

  • 21. Therapeutic Strategies for Spinocerebellar Ataxia Type 1.
    Kerkhof LMC; van de Warrenburg BPC; van Roon-Mom WMC; Buijsen RAM
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional rescue of spinocerebellar ataxia type 1 phenotypes by 14-3-3epsilon haploinsufficiency in mice underscores complex pathogenicity in neurodegeneration.
    Jafar-Nejad P; Ward CS; Richman R; Orr HT; Zoghbi HY
    Proc Natl Acad Sci U S A; 2011 Feb; 108(5):2142-7. PubMed ID: 21245341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes.
    Bowman AB; Lam YC; Jafar-Nejad P; Chen HK; Richman R; Samaco RC; Fryer JD; Kahle JJ; Orr HT; Zoghbi HY
    Nat Genet; 2007 Mar; 39(3):373-9. PubMed ID: 17322884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebellar contribution to the cognitive alterations in SCA1: evidence from mouse models.
    Asher M; Rosa JG; Rainwater O; Duvick L; Bennyworth M; Lai RY; ; Kuo SH; Cvetanovic M
    Hum Mol Genet; 2020 Jan; 29(1):117-131. PubMed ID: 31696233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1.
    Ding Y; Adachi H; Katsuno M; Sahashi K; Kondo N; Iida M; Tohnai G; Nakatsuji H; Sobue G
    Neuroscience; 2016 Jul; 327():20-31. PubMed ID: 27058144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice.
    Qu W; Johnson A; Kim JH; Lukowicz A; Svedberg D; Cvetanovic M
    J Neuroinflammation; 2017 May; 14(1):107. PubMed ID: 28545543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1.
    Coffin SL; Durham MA; Nitschke L; Xhako E; Brown AM; Revelli JP; Villavicencio Gonzalez E; Lin T; Handler HP; Dai Y; Trostle AJ; Wan YW; Liu Z; Sillitoe RV; Orr HT; Zoghbi HY
    Neuron; 2023 Feb; 111(4):481-492.e8. PubMed ID: 36577402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ataxin-1 regulates proliferation of hippocampal neural precursors.
    Asher M; Johnson A; Zecevic B; Pease D; Cvetanovic M
    Neuroscience; 2016 May; 322():54-65. PubMed ID: 26876606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.
    Ingram M; Wozniak EAL; Duvick L; Yang R; Bergmann P; Carson R; O'Callaghan B; Zoghbi HY; Henzler C; Orr HT
    Neuron; 2016 Mar; 89(6):1194-1207. PubMed ID: 26948890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.
    Lim J; Crespo-Barreto J; Jafar-Nejad P; Bowman AB; Richman R; Hill DE; Orr HT; Zoghbi HY
    Nature; 2008 Apr; 452(7188):713-8. PubMed ID: 18337722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR760 regulates ATXN1 levels via interaction with its 5' untranslated region.
    Nitschke L; Tewari A; Coffin SL; Xhako E; Pang K; Gennarino VA; Johnson JL; Blanco FA; Liu Z; Zoghbi HY
    Genes Dev; 2020 Sep; 34(17-18):1147-1160. PubMed ID: 32763910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1.
    Cvetanovic M; Ingram M; Orr H; Opal P
    Neuroscience; 2015 Mar; 289():289-99. PubMed ID: 25595967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1.
    Zoghbi HY; Orr HT
    J Biol Chem; 2009 Mar; 284(12):7425-9. PubMed ID: 18957430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BDNF is altered in a brain-region specific manner and rescues deficits in Spinocerebellar Ataxia Type 1.
    Rosa JG; Hamel K; Soles A; Sheeler C; Borgenheimer E; Gilliat S; Sbrocco K; Ghanoum F; Handler HP; Forster C; Rainwater O; Cvetanovic M
    Neurobiol Dis; 2023 Mar; 178():106023. PubMed ID: 36724861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purkinje cell ataxin-1 modulates climbing fiber synaptic input in developing and adult mouse cerebellum.
    Ebner BA; Ingram MA; Barnes JA; Duvick LA; Frisch JL; Clark HB; Zoghbi HY; Ebner TJ; Orr HT
    J Neurosci; 2013 Mar; 33(13):5806-20. PubMed ID: 23536093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise and genetic rescue of SCA1 via the transcriptional repressor Capicua.
    Fryer JD; Yu P; Kang H; Mandel-Brehm C; Carter AN; Crespo-Barreto J; Gao Y; Flora A; Shaw C; Orr HT; Zoghbi HY
    Science; 2011 Nov; 334(6056):690-3. PubMed ID: 22053053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5'UTR-mediated regulation of Ataxin-1 expression.
    Manek R; Nelson T; Tseng E; Rodriguez-Lebron E
    Neurobiol Dis; 2020 Feb; 134():104564. PubMed ID: 31381977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis of the phosphorylation dependent complex formation of neurodegenerative disease protein Ataxin-1 and RBM17.
    Kim E; Lee Y; Choi S; Song JJ
    Biochem Biophys Res Commun; 2014 Jul; 449(4):399-404. PubMed ID: 24858692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.
    Lam YC; Bowman AB; Jafar-Nejad P; Lim J; Richman R; Fryer JD; Hyun ED; Duvick LA; Orr HT; Botas J; Zoghbi HY
    Cell; 2006 Dec; 127(7):1335-47. PubMed ID: 17190598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776.
    Duvick L; Barnes J; Ebner B; Agrawal S; Andresen M; Lim J; Giesler GJ; Zoghbi HY; Orr HT
    Neuron; 2010 Sep; 67(6):929-35. PubMed ID: 20869591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.